Keywords: India, Patent law, Novartis, MSF, Supreme Court

MSF accuses Novartis of trying to weaken Indian patent law

Article | 06 September 2011

Print This

Novartis (NOVN: VX ) goes before the Indian Supreme Court today in the latest attempt by the Swiss multinational pharmaceutical company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in